Bedell Cindi Holt
Roche Laboratories, Inc., Nutley, NJ, USA.
Clin J Oncol Nurs. 2003 Nov-Dec;7(6 Suppl):5-9. doi: 10.1188/03.CJON.S6.5-9.
The development of numerous oral chemotherapy agents has led to a new paradigm in cancer treatment. Oral chemotherapy can be self-administered conveniently, so patients with cancer can receive their treatments in their homes instead of in a supervised and controlled healthcare environment. Cancer now is recognized as a treatable chronic disease, and new oral chemotherapy agents have been developed that offer targeted cancer treatment. Although the newer oral chemotherapy agents offer additional treatment options, they also pose challenges for patients and healthcare providers. Patient adherence and monitoring can be challenging, and reimbursement issues abound. Oncology nurses play a key role in assessing, educating, and monitoring patients receiving oral chemotherapy. In addition, they may be involved in assisting patients with obtaining reimbursement and, in some cases, may be instrumental in locating patient assistance programs. This article discusses patient care issues related to treatment with oral chemotherapy agents and provides a historical overview of their development and use.
众多口服化疗药物的研发引领了癌症治疗的新范式。口服化疗可由患者自行方便地给药,因此癌症患者能够在家中接受治疗,而非在有监督和管控的医疗环境中。癌症如今被视为一种可治疗的慢性病,并且已研发出新型口服化疗药物,可提供靶向癌症治疗。尽管新型口服化疗药物提供了更多治疗选择,但它们也给患者和医疗服务提供者带来了挑战。患者的依从性和监测颇具挑战,报销问题也层出不穷。肿瘤专科护士在评估、教育和监测接受口服化疗的患者方面发挥着关键作用。此外,他们可能会参与协助患者获得报销,在某些情况下,还可能有助于找到患者援助项目。本文讨论了与口服化疗药物治疗相关的患者护理问题,并对其研发和使用进行了历史概述。